PPP
BMY icon

Private Portfolio Partners’s Bristol-Myers Squibb BMY Stock Holding History

Private Portfolio Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.27M Sell
22,403
-129
-0.6% -$7.21K 0.23% 75
2024
Q3 		$1.17M Buy
+22,532
New +$1.06M 0.22% 82
2024
Q2 		– Sell
-26,441
Closed -$1.43M – 107
2024
Q1 		$1.43M Sell
26,441
-1,948
-7% -$99.2K 0.3% 62
2023
Q4 		$1.46M Sell
28,389
-2,480
-8% -$130K 0.33% 58
2023
Q3 		$1.79M Sell
30,869
-5,444
-15% -$334K 0.46% 46
2023
Q2 		$2.32M Sell
36,313
-2,537
-7% -$170K 0.6% 35
2023
Q1 		$2.69M Buy
38,850
+136
+0.4% +$9.59K 0.73% 28
2022
Q4 		$2.79M Buy
38,714
+78
+0.2% +$5.88K 0.73% 31
2022
Q3 		$2.75M Sell
38,636
-241
-0.6% -$17.5K 0.78% 29
2022
Q2 		$2.99M Sell
38,877
-200
-0.5% -$15.2K 0.83% 29
2022
Q1 		$2.85M Buy
39,077
+706
+2% +$47.4K 0.7% 33
2021
Q4 		$2.39M Buy
38,371
+1,264
+3% +$74.1K 0.61% 39
2021
Q3 		$2.2M Sell
37,107
-800
-2% -$52.7K 0.63% 39
2021
Q2 		$2.53M Sell
37,907
-1,475
-4% -$96.2K 0.73% 32
2021
Q1 		$2.49M Buy
39,382
+21
+0.1% +$1.31K 0.81% 29
2020
Q4 		$2.44M Buy
39,361
+320
+0.8% +$19.7K 0.86% 29
2020
Q3 		$2.35M Buy
39,041
+906
+2% +$54.5K 0.95% 26
2020
Q2 		$2.24M Buy
38,135
+270
+0.7% +$16.1K 1.04% 21
2020
Q1 		$2.11M Buy
37,865
+1,080
+3% +$66K 1.12% 22
2019
Q4 		$2.36M Buy
36,785
+3,931
+12% +$225K 1.02% 23
2019
Q3 		$1.67M Sell
32,854
-227
-0.7% -$10.7K 0.78% 34
2019
Q2 		$1.5M Buy
33,081
+6,549
+25% +$305K 0.64% 45
2019
Q1 		$1.27M Sell
26,532
-795
-3% -$39.6K 0.67% 43
2018
Q4 		$1.42M Buy
+27,327
New +$1.47M 0.88% 29

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Private Portfolio Partners's BMY Position: Q4 2024 in Review

Private Portfolio Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.57% in Q4 2024, selling an estimated $7.21K and leaving 22,403 shares worth $1.27M. The position accounts for 0.23% of the portfolio, ranked #75.

Private Portfolio Partners first reported a position in BMY in Q4 2018 and has held it in 24 quarters since. The position peaked at $2.99M in Q2 2022. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Private Portfolio Partners held 22,403 shares of Bristol-Myers Squibb worth $1.27M as of Q4 2024.
  • Private Portfolio Partners sold 129 Bristol-Myers Squibb shares in Q4 2024, an estimated $7.21K.
  • Bristol-Myers Squibb made up 0.23% of Private Portfolio Partners's portfolio in Q4 2024, its #75 holding.
  • Private Portfolio Partners first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 24 quarters since.
  • Private Portfolio Partners's Bristol-Myers Squibb position peaked at $2.99M in Q2 2022.
  • 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Private Portfolio Partners's 13F filing for Q4 2024, filed 12 Feb 2025.